Having long been considered to have ‘no accepted medical use’, psychedelics are finally being recognised as being beneficial for treating a range of mental health disorders.
The story of Anne Hamilton-Byrne’s cult The Family has been told in a non-fiction book and documentary, a novel, In the Clearing, and now a Disney+ series. What can stories like this teach us?
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
While ‘The Last of Us’ is a dramatic projection of a deadly fungal outbreak, it is based, if not in reality, in logic. And it’s a reminder that fungal infections are growing more resistant.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
Growing interest in psychedelics has spurred new research decades after hallucinogenics were tested in Saskatchewan in the 1950s. And an unassuming common fish is proving a useful test subject.
In a new research study, more than 900 people from around the world explain the challenges and benefits of microdosing LSD and psilocybin-containing mushrooms.
According to new research, individuals who take small regular doses of psychedelics such as LSD and psilocybin mushrooms score higher on mental health, well-being and creativity.
To know the real promise of psychedelic substances like LSD, mushrooms and MDMA, researchers must embrace the principles and practise of ‘open science.’
Once associated with mind-control experiments and counter-cultural defiance, psychedelics now show great promise for mental health treatments and may prompt a re-evaluation of the scientific method.
Psychedelic drugs have inspired great songs and works of art. But they may also have potential for treating disease like depression and PTSD by helping to regrow damaged regions of the brain.